Solara Active Pharma Sciences Limited (BOM:541540)
India flag India · Delayed Price · Currency is INR
499.60
+19.50 (4.06%)
At close: Feb 13, 2026

BOM:541540 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
5.4-5,674-221.8-581.52,214
Depreciation & Amortization
974.81,0111,0661,0811,056
Other Amortization
17.721.946.141.930.9
Loss (Gain) From Sale of Assets
-19.74.57.7-20
Asset Writedown & Restructuring Costs
0.825.3---
Stock-Based Compensation
26.860.5-13.151.4
Provision & Write-off of Bad Debts
10.2109.956.688.2-
Other Operating Activities
1,0623,662603.493.1281
Change in Accounts Receivable
198.11,782-528-145.5-2,574
Change in Inventory
418130.8173.2-2,806-152.4
Change in Accounts Payable
-594.373389-238.8966.7
Change in Other Net Operating Assets
8.4-79.2-26.852.2-299
Operating Cash Flow
2,1281,0891,563-2,4201,555
Operating Cash Flow Growth
95.48%-30.32%---35.80%
Capital Expenditures
-399.4-410.6-1,113-2,086-1,745
Sale of Property, Plant & Equipment
3.810.4131.329.7
Divestitures
9.6----
Investment in Securities
---12.8--1
Other Investing Activities
17.741.6125-343.6653.1
Investing Cash Flow
-368.3-35.1-811.4-2,429-1,063
Short-Term Debt Issued
-1,115394.42,48768.2
Long-Term Debt Issued
750496832,6241,558
Total Debt Issued
7501,1641,0775,1111,626
Short-Term Debt Repaid
-1,854----
Long-Term Debt Repaid
-1,131-1,194-1,331-962.2-2,654
Total Debt Repaid
-2,985-1,194-1,331-962.2-2,654
Net Debt Issued (Repaid)
-2,235-30.2-253.14,149-1,028
Issuance of Common Stock
1,590--292,982
Common Dividends Paid
----107.8-197.3
Other Financing Activities
-1,160-1,026-874.5-734-831.9
Financing Cash Flow
-1,805-1,057-1,1283,336924.9
Net Cash Flow
-44.9-2.9-376.5-1,5131,417
Free Cash Flow
1,729678.1449.4-4,507-190.2
Free Cash Flow Growth
154.95%50.89%---
Free Cash Flow Margin
13.47%5.26%3.11%-35.53%-1.18%
Free Cash Flow Per Share
43.3317.7512.48-125.38-5.54
Cash Interest Paid
1,1311,035-734831.9
Cash Income Tax Paid
9-9-135.4181333.6
Levered Free Cash Flow
595.652,768-82.46-5,069-957.98
Unlevered Free Cash Flow
1,2793,402460.04-4,616-455.85
Change in Working Capital
30.21,9067.4-3,138-2,058
Source: S&P Global Market Intelligence. Standard template. Financial Sources.